Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Anderlini

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Transfusion|May 1, 1997
Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastimP Anderlini, D Przepiorka, C Seong, et al.
Cytotherapy|September 15, 2009
Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel systemD Przepiorka, J G Lu, P Anderlini, et al.
Blood|May 23, 2001
Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donorsD Przepiorka, T L Smith, J Folloder, et al.
Journal of Clinical Apheresis|December 18, 2001
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresisM Körbling, S Giralt, I Khouri, et al.
British Journal of Haematology|August 6, 2000
A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donorsP Anderlini, M Donato, M J Lauppe, et al.
Transfusion|July 1, 1996
Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the proceduresP Anderlini, D Przepiorka, D Seong, et al.
Transfusion|June 23, 1999
Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experienceP Anderlini, M Donato, K W Chan, et al.
Bone Marrow Transplantation|April 1, 2003
Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and resultsN Apisarnthanarax, M Donato, M Körbling, et al.
Blood|September 6, 2001
Chronic graft-versus-host disease after allogeneic blood stem cell transplantationD Przepiorka, P Anderlini, R Saliba, et al.
Leukemia|June 1, 1996
Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the firstP Anderlini, H M Ghaddar, T L Smith, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Transfusion|May 1, 1997
Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastimP Anderlini, D Przepiorka, C Seong, et al.
Cytotherapy|September 15, 2009
Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel systemD Przepiorka, J G Lu, P Anderlini, et al.
Blood|May 23, 2001
Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donorsD Przepiorka, T L Smith, J Folloder, et al.
Journal of Clinical Apheresis|December 18, 2001
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresisM Körbling, S Giralt, I Khouri, et al.
British Journal of Haematology|August 6, 2000
A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donorsP Anderlini, M Donato, M J Lauppe, et al.
Transfusion|July 1, 1996
Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the proceduresP Anderlini, D Przepiorka, D Seong, et al.
Transfusion|June 23, 1999
Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experienceP Anderlini, M Donato, K W Chan, et al.
Bone Marrow Transplantation|April 1, 2003
Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and resultsN Apisarnthanarax, M Donato, M Körbling, et al.
Blood|September 6, 2001
Chronic graft-versus-host disease after allogeneic blood stem cell transplantationD Przepiorka, P Anderlini, R Saliba, et al.
Leukemia|June 1, 1996
Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the firstP Anderlini, H M Ghaddar, T L Smith, et al.
Pageof 9